Coffee and tea drinking and risk of cancer of the urinary tract in male smokers.
Adult
Aged
Carcinoma, Renal Cell
/ epidemiology
Coffee
/ adverse effects
Cohort Studies
Female
Finland
/ epidemiology
Humans
Incidence
Male
Middle Aged
Prospective Studies
Risk Assessment
Tea
/ adverse effects
Urinary Bladder Neoplasms
/ epidemiology
Urologic Neoplasms
/ epidemiology
alpha-Tocopherol
beta Carotene
Bladder cancer
Caffeine
Catechin
Coffee
Renal cell carcinoma
Tea
Journal
Annals of epidemiology
ISSN: 1873-2585
Titre abrégé: Ann Epidemiol
Pays: United States
ID NLM: 9100013
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
08
11
2018
revised:
26
03
2019
accepted:
30
03
2019
pubmed:
27
4
2019
medline:
23
2
2020
entrez:
27
4
2019
Statut:
ppublish
Résumé
We evaluated the association of coffee and tea drinking with risk of the urinary tract cancer in Finnish men, with high coffee consumption, using data from the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. The ATBC trial conducted from 1985 to 1993 enrolled 29,133 male smokers. We used Cox proportional hazards regression models to estimate hazard ratios (HRs) and confidence intervals (CIs), using men who drank more than 0 but less than 1 cup coffee/d and tea nondrinkers as our referent group for coffee and tea analyses, respectively. During 472,402 person-years of follow-up, 835 incident cases of bladder cancer and 366 cases of renal cell carcinoma were ascertained. For bladder cancer, we observed no association for coffee consumption (HR ≥4 vs. >0 to <1 cups/d = 1.16, 95% CI = 0.86-1.56) and a borderline statistically significant inverse association for tea consumption (HR ≥1 vs. 0 cup/d = 0.77, 95% CI = 0.58-1.00). For renal cell carcinoma, we observed no association for coffee (HR ≥4 vs. >0 to <1 cups/d = 0.85, 95% CI = 0.55-1.32) or tea consumption (HR ≥1 vs. 0 cup/d = 1.00, 95% CI = 0.68-1.46). We found no impact of coffee preparation on coffee-cancer associations. Coffee drinking was not associated with urinary tract cancers risk. Further research on tea and bladder cancer is warranted.
Identifiants
pubmed: 31023511
pii: S1047-2797(18)31010-X
doi: 10.1016/j.annepidem.2019.03.014
pmc: PMC6684125
mid: NIHMS1535777
pii:
doi:
Substances chimiques
Coffee
0
Tea
0
beta Carotene
01YAE03M7J
alpha-Tocopherol
H4N855PNZ1
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
33-39Subventions
Organisme : Intramural NIH HHS
ID : ZIA CP010195-12
Pays : United States
Informations de copyright
Published by Elsevier Inc.
Références
Int J Cancer. 2012 Oct 1;131(7):1700-10
pubmed: 22190017
JAMA Oncol. 2015 Dec;1(9):1282-90
pubmed: 26448641
Prev Med. 2012 Jul;55(1):14-22
pubmed: 22564775
Acta Oncol. 2002;41(4):381-8
pubmed: 12234031
Epidemiology. 2017 Sep;28(5):685-693
pubmed: 28768299
Plant Foods Hum Nutr. 2012 Sep;67(3):277-82
pubmed: 22766993
Eur J Cancer. 2017 May;77:31-39
pubmed: 28350996
Am J Epidemiol. 1988 Sep;128(3):655-66
pubmed: 2458036
Anticancer Agents Med Chem. 2015;15(1):26-36
pubmed: 25482719
Intern Med J. 2017 Dec;47(12):1422-1432
pubmed: 28892303
Food Chem Toxicol. 2002 Aug;40(8):1155-63
pubmed: 12067578
Br J Cancer. 2013 Sep 3;109(5):1344-51
pubmed: 23880821
Eur J Cancer Prev. 2017 Mar;26(2):125-130
pubmed: 26882077
Ann Chir Gynaecol. 1987;76(4):185-90
pubmed: 3434988
Eur Urol. 2017 Jan;71(1):96-108
pubmed: 27370177
Front Physiol. 2017 Jan 23;7:693
pubmed: 28167914
BMC Gastroenterol. 2013 Feb 25;13:34
pubmed: 23433483
Cancer Lett. 2007 Mar 8;247(1):26-39
pubmed: 16709440
Int J Cancer. 2007 Nov 15;121(10):2246-53
pubmed: 17583573
Sci Rep. 2015 Mar 12;5:9051
pubmed: 25761588
Br J Cancer. 2015 Sep 1;113(5):809-16
pubmed: 26291054
Eur J Cancer Prev. 2015 Jul;24(4):353-62
pubmed: 25370683
Ann Epidemiol. 1994 Jan;4(1):1-10
pubmed: 8205268